Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Non-myeloablative BMT with PTCy for Refractory SAA
NCT02224872Phase 2Completed
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Aug 2014
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide in aplastic anemia, bone marrow failure syndrome (BMFS), sponsored by Sidney Kimmel Comprehensive Cancer Center. Started Aug 2014; status: completed.
02
Drugs
cyclophosphamide
03
Conditions
aplastic anemiabone marrow failure syndrome (BMFS)
Beyond the preview
Go deeper on NCT02224872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02224872.